First-time generic approvals
A discussion of generic drugs recently approved by FDA
Key Points
Ranitidine oral solution, 15 mg/mL (equiv to Zantac syrup)
ACTAVIS
Didanosine for oral solution, 10 mg/mL (equiv to Videx Pediatric Powder for oral solution)
AUROBINDO
Moexipril/hydrochlorothiazide tablets, 12.5/7.5 mg, 25/15 mg, and 12.5/15 mg (equiv to Uniretic tablets)
TEVA
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
